MetaCap

ImageneBio Insider Trades

NASDAQ: IMAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

3.920.00 (0.00%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
1 · $95.84K
Sales
2 · $17.33K
Shares bought / sold
16.00K / 3.20K
Net activity
Net buying $78,506

ImageneBio insider activity

Over the last 12 months, ImageneBio insiders reported 10 transactions on SEC Form 4: 1 open-market purchase and 2 sales. Insiders bought $95,840 and sold $17,334 worth of stock, for net insider buying of $78,506. The largest seller was Lally Robert B, with $17,334 in reported sales.

The most recent filing shows Yarema Kristin (Chief Executive Officer) reporting a transaction in 254,800 shares on Aug 14, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put IMA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

IMA insider transactions

ImageneBio insider transactions
DateInsiderTypeSharesValueFiling
Aug 14, 2026Grant-Huerta YaninaChief Financial OfficerAward39,000—Form 4
Aug 14, 2026Grant-Huerta YaninaChief Financial OfficerAward65,000—Form 4
Aug 14, 2026Yarema KristinChief Executive OfficerAward254,800—Form 4
Jul 25, 2026Yarema KristinChief Executive Officerother115,129—Form 4
Jul 25, 2026Yarema KristinChief Executive OfficerOption exercise38,376—Form 4
Jul 17, 2026Lally Robert BPrincipal Accounting OfficerSale1,525$8.14KForm 4
Jul 16, 2026Lally Robert BPrincipal Accounting OfficerSale1,671$9.19KForm 4
Mar 16, 2026Yarema KristinChief Executive OfficerAward85,400—Form 4
Dec 30, 2025Butler ErinPrincipal Accounting OfficerAward22,500—Form 4
Dec 24, 2025SLATTERY JOSEPH PDirectorBuy16,000$95.84KForm 4
Jul 28, 2025Marango JotinChief Financial OfficerTax withholding4,630$79.45KForm 4
Jul 28, 2025Marango JotinChief Financial OfficerAward15,776—Form 4
Jul 25, 2025Butler ErinPrincipal Accounting OfficerAward3,051—Form 4
Jul 25, 2025Bonita David PDirectorBuy83,611$2.50MForm 4
Jul 25, 2025Bonita David PDirectorOption exercise379—Form 4
Jul 25, 2025Stampacchia OtelloDirectorBuy267,556$8.00MForm 4
Jul 25, 2025Stampacchia OtelloDirectorOption exercise379—Form 4
Jul 25, 2025ORBIMED ADVISORS LLC & OrbiMed Capital GP VI LLC & OrbiMed Genesis GP LLCDirectorAward83,611$208.19KForm 4
Jul 25, 2025Wang Jonathan JianDirectorAward971,173—Form 4
Jul 25, 2025Wang Jonathan JianDirectorAward143,832—Form 4
Jul 25, 2025Wang Stephen HuiDirectorAward12,535—Form 4
Jul 25, 2025Wang Stephen HuiDirectorAward50,144—Form 4
Jul 25, 2025Wang Stephen HuiDirectorAward188,042—Form 4
Aug 4, 2023Bonita David PDirectorAward153,121—Form 4
Aug 4, 2023ORBIMED ADVISORS LLC & OrbiMed Capital GP VI LLC & OrbiMed Genesis GP LLCDirectorAward153,121—Form 4
Aug 4, 2023ORBIMED ADVISORS LLC & OrbiMed Capital GP VI LLC & OrbiMed Genesis GP LLCDirectorAward153,121—Form 4
Aug 4, 2023Bonita David PDirectorAward153,121—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related